abstract |
The present invention relates to specific conjugates of cytotoxic drugs and prodrug forms of such conjugates for use in treating cancer and inflammatory diseases. Conjugates are represented by formula (I), and pharmaceutically acceptable salts thereof: [Wherein, A represents a radical derived from a cytotoxic drug, G is a self-sacrificing moiety, and m is 0 or 1]. |